Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 301-320 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 301 | Emposat lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only gives contextual membership rationale that Emposat provides ground-station access used in connection with a surveillance satellite, which is too indirect to support a durable positive investment thesis without direct within the recent evidence window business evidence. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Emposat. Caveats: Phase-2 membership rationale references articles and, but the reviewed sources provide no for citation. Ground-station context is indirect and not enough for a strong thesis under the evidence standard. |
| 302 | EnduroSat lowweak | Opp 1 Risk 1 | Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the selected recent evidence window, despite membership rationale describing EnduroSat as a space infrastructure and satellite-constellation builder. Why now: Why now is unsupported because no evidence remain after recent evidence filtering; there is no dated catalyst, financing, contract, production, or customer evidence available here. Caveats: No surviving evidence after recent evidence filtering. Reviewed evidence counts indicate evidence existed upstream, but none is included here for direct citation. Low scores reflect missing evidence, not a fundamental negative judgment. |
| 303 | EON Space Labs lowweak | Opp 1 Risk 3 | Thesis: No positive thesis is supportable from the scoring evidence fields because no direct positive evidence are provided. Why now: Why now is stronger than for most names here because the phase2 rationale specifically ties EON Space Labs to a PSLV failure context via article: implying a concrete event rather than generic company context. However, conviction remains low because the reviewed sources omits the underlying event summary and dates in the evidence exposed here. Caveats: The adverse signal appears only in phase2 rationale, not in direct negative evidence. No article summary, quote, or timing detail is provided in the scoring fields. Impact magnitude on EON specifically cannot be quantified from these reviewed sources alone. |
| 304 | FOSSA Systems lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources' membership rationale says FOSSA Systems has launched 24 satellites, is deploying an 80-satellite constellation, and has defense customers, but there are no available direct positive evidence or dated representative articles within the reviewed sources for scoring, so opportunity remains only a watchlist possibility. Why now: No within the recent evidence window evidence are available after filtering, so there is no near-dated trigger or state change that can be scored from the local reviewed sources. Caveats: Membership support references article, but that article content is not available here for direct citation. Coverage debug shows zero evidence after recent evidence window. A positive thesis requires positive evidence, not just category fit or membership rationale. |
| 305 | GalaxEye Space Solutions Private Ltd lowweak | Opp 1 Risk 2 | Thesis: The company belongs in the cohort as an Earth observation / SAR startup, but these reviewed sources provide no available within the recent evidence window directional evidence to support a strong 1 year+ opportunity thesis. Why now: There is no within the recent evidence window evidence available for this entity in the reviewed sources; recency of any business progress is uncertain. Caveats: Evidence recent evidence review shows 0 kept rows after the 90-day cutoff for this entity. Membership rationale references article IDs, and: but no article summaries or direct evidence are included in these reviewed sources for citation-level use. Scores are constrained by absence of directional evidence, not by a proven negative business outcome. |
| 306 | GE Aerospace lowweak | Opp 1 Risk 1 | Thesis: No reviewed sources-supported positive thesis is available. The company is only described as appearing in generic 'space stocks' context, while direct positive evidence after the 90-day recent evidence window is absent. Why now: There is no current catalyst in the reviewed sources. Coverage shows 32 article IDs considered but zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency-based ranking is not supported. Caveats: Phase2 rationale says only generic stock-screener style article context was available, citing article IDs, and, but no were provided in the reviewed sources. Evidence recent evidence review shows no current evidence was retained and undated_rows_kept = 0. Without for the cited membership-support articles, they cannot be used as factual thesis evidence under the citation requirement. |
| 307 | Gilat Satellite Networks Ltd. lowweak | Opp 1 Risk 1 | Thesis: Insufficient retained local evidence within the 90-day recent evidence window to support a positive 1 year+ opportunity thesis. Why now: No company-specific dated evidence were retained after the 90-day recent evidence window cutoff of March 29, 2026, so there is no current catalyst basis in the reviewed sources. Caveats: Reviewed evidence shows 64 articles considered but 0 article IDs after recent evidence window and 0 evidence retained. Membership support cited article IDs: and: but no article summaries or retained evidence are provided in these reviewed sources, so no factual thesis claims can be grounded from them. |
| 308 | Hensoldt AG lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources offers no direct positive company-specific evidence within the available scoring set. The membership rationale says Hensoldt appears in a market report as one of many key players in the space situational awareness market, but that is article-level market-list context rather than direct business evidence, and no available evidence remain after recent evidence window. Why now: No near-term or durable catalyst is established from the available evidence. Coverage debug shows 69 article IDs considered but 0 after recent evidence window and 0 evidence after dedupe. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Only context-level market-list mention is described, not a direct event or fact. |
| 309 | HEO USA lowweak | Opp 1 Risk 1 | Thesis: A limited positive angle exists because the membership rationale says a HEO camera achieved sub-5-meter resolution in Sidus Space's earnings context, implying technical relevance (: and: unavailable in reviewed sources). However, this appears indirect and counterparty/component context rather than direct company evidence, so opportunity remains low. Why now: Why now is weak because the cited technical-performance context is indirect, and the reviewed sources explicitly warns that relations are context-only and should not be used as counterparty propagation evidence. Caveats: No current evidence is provided for: and Counterparty/component context is not strong direct evidence for HEO USA itself. Zero evidence available after recent evidence window. |
| 310 | Hermeus Corporation lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available. The reviewed sources say Hermeus is only mentioned as one of several companies expanding in California in an article about Skydio, which is too indirect to support a durable positive thesis. Why now: There is no current timing signal from the reviewed sources. Coverage debug shows 29 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. The only described mention is indirect article context. |
| 311 | HughesNet lowweak | Opp 1 Risk 2 | Thesis: The reviewed sources places HughesNet within satellite broadband and communication services context via EchoStar, but there is no direct reviewed evidence in the 90-day window to support a differentiated 1 year+ opportunity thesis. Why now: There is no validated near-term or long-term catalyst from active evidence. The reviewed sources cites article in membership support, but the company coverage section shows zero articles after recent evidence window and zero evidence after recent evidence window, so recency-backed thesis formation is not possible. Caveats: High article count does not equal conviction; no post-recent evidence window evidence was available. No direct company-specific event/fact evidence is available in the output reviewed sources. |
| 312 | Impulso lowweak | Opp 1 Risk 1 | Thesis: There is no direct positive evidence in the available scoring set. The reviewed sources say Impulso is mentioned only as GalaxEye's distribution agreement counterparty, which does not establish Impulso's own business opportunity. Why now: No timing catalyst is supported by the reviewed sources. Coverage debug shows 1 article considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Counterparty context cannot be propagated into a direct thesis. |
| 313 | Infinite Orbits lowweak | Opp 1 Risk 1 | Thesis: Potential long-horizon opportunity exists if the previously referenced multi-launch agreement for servicing satellites remains active, but the reviewed sources provide no retained within the recent evidence window positive evidence to support a current thesis. Why now: There is no qualifying 90-day retained evidence. The only cited article mentioning Infinite Orbits is dated September 16, 2025, outside the reviewed sources' 90-day recent evidence window, so recency for any business progress is not established. Caveats: Reviewed evidence shows zero evidence retained after recent evidence window. Do not use the older TechCrunch article as current recency proof. Absence of recent negative evidence is not positive evidence. |
| 314 | Integrate lowweak | Opp 1 Risk 1 | Thesis: No current positive thesis is supportable within the reviewed sources' retained recent evidence window evidence. Why now: Why now is weak because the only specific company article summary in the reviewed sources were dated February 23, 2026 and was dropped by the 90-day recent evidence window, so it cannot support current ranking despite mentioning financing and a Space Force contract, February 23, 2026). Caveats: The reviewed sources contain a representative article summary for stating Integrate 'closed a $17M Series A and landed a $25M space force contract to deploy secure program management software,' but the evidence recent evidence review says those rows were dropped as older than the March 29, 2026 cutoff, so they are not usable for current scoring. The company may be space-adjacent software rather than a direct space operator, per the reviewed sources' own membership rationale. |
| 315 | Integrated Launch Solutions, Inc. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported from retained evidence because the reviewed sources contain no direct positive rows within the recent evidence window. Why now: No current catalyst is evidenced in retained rows. Caveats: Phase-2 rationale says ILS provides engineering, mission design, range integration, and support for the STARLAUNCH pathway and cites: and: but neither summary nor is available here for citation. Coverage debug shows 7 articles considered and 0 after recent evidence window. Service-provider context alone is not directional proof without retained positive or negative evidence. |
| 316 | Integrity ISR lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported because there is no retained direct positive evidence within the reviewed sources' recent evidence window. Why now: No current business change or catalyst is evidenced in the retained rows. Caveats: Phase-2 rationale references: about analysis of satellite maneuvers near an ICEYE satellite, but no or article summary is provided here for citation. Coverage debug shows 1 article considered and 0 after recent evidence window. Single-article descriptive context in phase-2 rationale is weaker than direct event/fact evidence and is uncitable here due to missing. |
| 317 | Israel Aerospace Industries lowweak | Opp 1 Risk 1 | Thesis: No admissible direct positive evidence was available inside the 90-day recent evidence window, so there is no supportable positive 1 year+ opportunity thesis from these reviewed sources alone. Why now: There is no usable current evidence in the reviewed sources for this company: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article: but no company-specific evidence are available for ranking use. unavailable in reviewed sources. Caveats: Reviewed evidence provides no post-recent evidence window evidence. Membership rationale is not directional proof. Referenced: has no in the reviewed sources. |
| 318 | Kepler Communications lowweak | Opp 1 Risk 1 | Thesis: Kepler may have long-horizon potential because the membership rationale says it operates an optical relay satellite network and is prime contractor on ESA HydRON optical communications work, but there is no available within the recent evidence window evidence in these reviewed sources to substantiate a directional score. Why now: There is no scoreable current catalyst because the reviewed sources contain no reviewed evidence after the 90-day recent evidence filter for this company. Caveats: Membership rationale cites, and, but the supporting article details are not available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. No current dated evidence means recency is uncertain. |
| 319 | Kessler Dynamics lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence hints only that Kessler Dynamics was listed in a spacetech accelerator with themes including rocket propulsion, satellites, and space energy, but no in-recent evidence window direct evidence or article is provided, so there is no supported positive thesis. Why now: There is no usable dated catalyst evidence in the reviewed sources for the 1 year+ horizon. The reviewed sources show 0 reviewed evidence after the 90-day cutoff and no representative article summary or for direct citation. Caveats: Coverage is effectively empty after recent evidence filtering: evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. The reviewed sources references support references including: but no or quote/summary is provided, so it cannot support factual claims under the citation rule. |
| 320 | KinetX lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available, so there is no supportable opportunity thesis from these reviewed sources alone. Why now: The only described context is that Intuitive Machines 'closed KinetX transaction' in article, but no business description, no, and no evidence are available after recent evidence filtering. Caveats: Acquisition context alone is not directional proof for KinetX. No company-specific operating facts are available. Referenced has no in the reviewed sources. |
Risk view
Showing rows 281-300 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 281 | COMSAT lowweak | Opp 0 Risk 1 | Thesis: No material adverse thesis is supported either. The reviewed sources only provides thin acquisition-context mention, so risk remains low-scored for lack of evidence rather than comfort. Why now: No 90-day article summaries or evidence were available for COMSAT in these reviewed sources, so there is no supported timing catalyst. Caveats: Relations/context-only style mention should not be used as counterparty propagation evidence. Phase2 rationale references article ids: and: but no or summaries are provided in the reviewed sources. No direct evidence were available after recent evidence window. |
| 282 | Comtech Telecommunications Corp. lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis can be supported from these reviewed sources because no direct negative evidence are provided within the recent evidence window. Why now: There is no usable company-specific evidence in the reviewed sources after recent evidence filtering; coverage data shows zero article IDs after recent evidence window and zero evidence available, so there is no current catalyst basis in these reviewed sources. Caveats: Absence of evidence is not positive evidence. Reviewed evidence notes only weak peer-group context in phase2 rationale, but no citable article details are included in the scoring fields. |
| 283 | Cosmoserve lowweak | Opp 1 Risk 1 | Thesis: No material adverse company-specific evidence is provided. The primary risk is simply that the evidence is too indirect to support a real thesis. Why now: No in-recent evidence window article summary or evidence row was available for Cosmoserve, so there is no supported catalyst timing. Caveats: The mention is article-level and indirect rather than company-specific. Phase2 rationale references article id: but no or summary is included. No direct evidence were available after recent evidence window. |
| 284 | Cosmoserve Space lowweak | Opp 1 Risk 1 | Thesis: No retained 90-day negative evidence supports a risk thesis. Why now: The reviewed sources retains zero evidence after the recent evidence filter, leaving no current catalyst or recency-supported business update. Caveats: Only one historical article was considered and none are retained within the recent evidence window. The single membership support item is not enough for a current directional call. This is effectively a watchlist placeholder until newer evidence appears. |
| 285 | Curtiss-Wright Corporation lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is available. The main risk is evidentiary weakness: supplier-beneficiary framing without direct contract, backlog, or financial evidence leaves the thesis unproven. Why now: Potentially relevant if broader space spending is increasing, but the reviewed sources provide no retained dated evidence, no current data, so timing and magnitude cannot be validated. Caveats: No current evidence is provided for Relation/context evidence must not be used as counterparty propagation; reviewed sources notes context only. No available direct evidence after recent evidence window despite high article count considered. |
| 286 | Deloitte lowweak | Opp 2 Risk 1 | Thesis: No material negative evidence is retained in the reviewed sources. Why now: The reviewed sources rationale says Deloitte launched satellites for Project Constellation to test on-orbit cyber protections and contracted Spire to design, build, and operate satellites, citing article, but no or retained evidence row is available after recent evidence window, limiting confidence. Caveats: The described activity comes only from membership rationale rather than retained evidence. Without retained dated evidence or, chronology and durability cannot be tested. |
| 287 | Digantara lowweak | Opp 1 Risk 1 | Thesis: No retained 90-day negative evidence supports a material risk call. Why now: Despite several historical mentions, the reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent catalyst evidence in the served data. Caveats: Historical support mentions approximately $50M funding, but the underlying evidence is not retained within the current recent evidence window reviewed sources. Low scores reflect missing current evidence, not a negative operating judgment. |
| 288 | Digantara lowweak | Opp 1 Risk 1 | Thesis: No direct adverse evidence is provided in the reviewed sources. The main issue is lack of current evidence within the recent evidence window, so risk cannot be ranked highly. Why now: There is no strong 'why now' because coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any thesis would be under-supported for current timing. Caveats: No evidence remained after the 90-day recent evidence window. Phase-2 membership rationale is not enough for a directional thesis by itself. Recency and business-state claims are unavailable in the reviewed sources. |
| 289 | DPhi Space lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supported. The main issue is lack of substantiated company-specific evidence. Why now: No available article summaries or evidence exist after recent evidence window for DPhi Space in these reviewed sources, so there is no supported why-now catalyst. Caveats: Support level is only provisional_single_article_context in the reviewed sources. Phase2 rationale references article id, but no or summary is included. No evidence were available after recent evidence window. |
| 290 | Elbit Systems Ltd. lowweak | Opp 1 Risk 1 | Thesis: Despite broad defense and geopolitical exposure implied by context, the reviewed sources have no direct negative evidence within the recent evidence window, so no adverse thesis is supportable. Why now: Membership rationale references articles: and, but coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources. Caveats: Large mention volume is not conviction. Defense-space context is not directional proof. Referenced have no in the reviewed sources. |
| 291 | Element U.S. Space & Defense lowweak | Opp 0 Risk 1 | Thesis: No direct adverse evidence is retained, but the company is especially thinly covered in these reviewed sources, which raises uncertainty rather than a demonstrable risk case. Why now: Why now is absent because only 2 articles were considered and none survived the 90-day filter; there is no current evidence basis for a 1 year+ directional call. Caveats: Coverage is extremely sparse. The only described relation is context/service oriented and relations are context-only unless policy-gated. No post-cutoff evidence available. |
| 292 | Emposat lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Emposat. Caveats: Phase-2 membership rationale references articles and, but the reviewed sources provide no for citation. Ground-station context is indirect and not enough for a strong thesis under the evidence standard. |
| 293 | EnduroSat lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is provided in the reviewed sources after recent evidence filtering, so a negative thesis is unsupported. Why now: Why now is unsupported because no evidence remain after recent evidence filtering; there is no dated catalyst, financing, contract, production, or customer evidence available here. Caveats: No surviving evidence after recent evidence filtering. Reviewed evidence counts indicate evidence existed upstream, but none is included here for direct citation. Low scores reflect missing evidence, not a fundamental negative judgment. |
| 294 | Filtronic PLC lowweak | Opp 2 Risk 1 | Thesis: No material adverse thesis is supported because no direct negative evidence is retained in the reviewed sources. Why now: There is no evidenced near-term or durable why-now catalyst inside the retained 90-day evidence window. Caveats: Reviewed evidence references but provides no representative article. Potentially positive older context may be stale or superseded; recency cannot be validated. No retained evidence after recent evidence window. |
| 295 | FOSSA Systems lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources, so there is no supported risk thesis beyond generic startup and execution uncertainty, which is insufficient under the evidence rules. Why now: No within the recent evidence window evidence are available after filtering, so there is no near-dated trigger or state change that can be scored from the local reviewed sources. Caveats: Membership support references article, but that article content is not available here for direct citation. Coverage debug shows zero evidence after recent evidence window. A positive thesis requires positive evidence, not just category fit or membership rationale. |
| 296 | Fujitsu lowweak | Opp 3 Risk 1 | Thesis: No material negative evidence is available. The main risk is that space may remain too small a contributor within Fujitsu's broader business to drive a distinct thesis, but this is an inference from the reviewed sources' boundary ambiguity rather than direct adverse evidence (: and; not provided in reviewed sources). Why now: An MOU in SDA could matter over a 1 year+ horizon if it converts into deployments or service revenue, but the reviewed sources offers no direct dated evidence inside recent evidence window and no article to validate timing. Caveats: Large diversified company; reviewed sources does not show materiality of space effort. MOU is weaker than signed commercial contract revenue evidence. No direct article content or is available in reviewed sources. |
| 297 | GE Aerospace lowweak | Opp 1 Risk 1 | Thesis: No reviewed sources-supported adverse thesis is available. There is also no material direct negative evidence after the 90-day recent evidence window. Why now: There is no current catalyst in the reviewed sources. Coverage shows 32 article IDs considered but zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency-based ranking is not supported. Caveats: Phase2 rationale says only generic stock-screener style article context was available, citing article IDs, and, but no were provided in the reviewed sources. Evidence recent evidence review shows no current evidence was retained and undated_rows_kept = 0. Without for the cited membership-support articles, they cannot be used as factual thesis evidence under the citation requirement. |
| 298 | Gilat Satellite Networks Ltd. lowweak | Opp 1 Risk 1 | Thesis: Insufficient retained local evidence within the 90-day recent evidence window to support a material adverse thesis. Why now: No company-specific dated evidence were retained after the 90-day recent evidence window cutoff of March 29, 2026, so there is no current catalyst basis in the reviewed sources. Caveats: Reviewed evidence shows 64 articles considered but 0 article IDs after recent evidence window and 0 evidence retained. Membership support cited article IDs: and: but no article summaries or retained evidence are provided in these reviewed sources, so no factual thesis claims can be grounded from them. |
| 299 | GS Yuasa Corporation lowweak | Opp 3 Risk 1 | Thesis: No material adverse evidence is retained. The main limitation is that the reviewed sources does not prove the scale, growth, or competitiveness of GS Yuasa's space exposure. Why now: There is no verified near-term catalyst, but the reviewed sources' phase-2 rationale references saying GS Yuasa was named as a key player in a space battery market report. Without, timing detail, or retained evidence, recency is uncertain. Caveats: The rationale cites, but no or retained article text is provided. Being listed as a key player in a market report is weaker than direct contract, launch, or financial evidence. No retained evidence remain after the 90-day recent evidence window. |
| 300 | HawkEye 360, Inc. lowweak | Opp 2 Risk 1 | Thesis: Government concentration or defense-program dependence could be a risk, but the reviewed sources contain no direct negative evidence within the available recent evidence window. Why now: There is no available post-recent evidence window evidence in the reviewed sources to establish a current catalyst or changed business state. Caveats: No evidence available after recent evidence window. Cannot rely on membership rationale alone for direction. |